Department of Medicine
|
David Alland, MD
|
Clinical Info
Hospital Affiliation
UMDNJ - University Hospital, Newark
Insurance Participation
Insurance Participation: with Provider Number ( where applicable ) The information below is subject to change and should not be relied upon until after it is verified with the insurance company. In addition, psychiatric providers should be contacted directly for information on their participation with managed care and insurance companies.
- AmeriGroup
- Beech Street Corp.
- CHN Solutions
- CIGNA
- Devon Health Services/ULLICO
- Group Health Incorporated
- Horizon BCBS Managed Care
- Horizon NJ Health
- Magnacare
- Medicaid
- Medicare
- MultiPlan
- Prime Health Services, Inc.
- Procura, Inc.
- Three Rivers Provider Network
- United Healthcare Community Plan (formerly AmeriChoice of NJ, Inc.)
| 12/18/2006 | |
| 5/1/2007 | |
| 10/6/2006 | |
| 12/15/2006 | |
| 7/27/2006 | |
| 1/1/2003 | |
| 10/16/2002 | |
| 10/16/2002 | |
| 10/27/2006 | |
| 1/1/2013 | |
| 3/15/2011 | |
| 7/1/2002 | |
| 8/1/2009 | |
| 9/13/2002 |
Last Updated:
Clinical Trial
Linezolid in The Treatment of Subjects with Complicated Skin and Soft Tissue Infections Proven to be due to Methicillin-Resistant Staphylococcus Aureus
Biography
OverviewThe Alland laboratory concentrates on many different aspects of M. tuberculosis molecular biology, epidemiology and diagnostics. Many of these areas are related to understanding how antibiotic resistance develops on both the cellular and epidemiological level.
Education
MD, 1984, Columbia College of Physicians and Surgeons
Licensure & Certification
Medical Licensure
New Jersey
Publications
|
Relevant Publications: |
| Colangeli R, Haq A, Arcus V.L, Summers E, Magliozzo R. S, McBride A, Mitra A.K, Radjainia M, Khajo A, Jacobs Jr. W. R, Salgame P, Alland D. The multi-functional histone-like protein Lsr2 protects mycobacteria against reactive oxygen intermediates. Proc. Nat. Acad. Sci. U.S.A. 2009, 106 :4414-4418. PMID: 19237572. |
| Tasslimi A, Sison E, Story E, Alland D , Burday M, Morrison S, Nalmas S, Smith S, Thomas PA, Wenger P, Sinha A. Disappearance of vaccine-type invasive pneumococcal disease (IPD) and emergence of serotype 19A in a minority population with high HIV prevalence and low childhood immunization rates. Clinical and Vaccine Immunology . 2009, 16 :1256-1259. PMID: 19515869 |
| Abadia E, Sequera M, Ortega D, Méndez MV, Escalona A, Da Mata O, Izarra E, Rojas Y, Jaspe R, Motiwala AS, Alland D , de Waard JH, Takiff HE. Mycobacterium tuberculosis ecology in Venezuela : Epidemiologic correlates of common spoligotypes and a large clonal cluster defined by MIRU-VNTR-24. BMC Infectious Diseases. 2009, 9 :122. PMID: 19660112. |
| Safi H, Fleischmann RD, Peterson SN, Jones MB, Jarrahi B, Alland D . Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis. Antimicrob Agents Chemother . 2010, 54 :103-108. PMID: 19822701. |
| Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, Safi H, Blakemore R, Lan NT, Jones-López EC, Levi M, Burday M, Ayakaka I, Mugerwa RD, McMillan B, Winn-Deen E, Christel L, Dailey P, Perkins MD, Persing DH, Alland D . Rapid detection of Mycobacterium tuberculosis and rifampin-resistance using on-demand, near patient technology. J Clin Microbiol . 2010, 48 :229-237. PMID: 19864480. |
| Chakravorty S, Aladegbami B, Burday M, Levi M, Marras SA, Shah D, El-Hajjj HH, Kramer FR, Alland D . Rapid Universal Identification of bacterial pathogens from clinical cultures by using a novel sloppy molecular beacon melting temperature signature technique. J Clin. MIcrobiol . 2010, 48 :258-267 PMID 19923485 |
| Motiwala AS, Dai Y, Jones EC, Hwang SH, Lee JS, Cho SN, Via LE, Barry CE 3 rd , Alland D . Mutations in extensively drug-resistant Mycobacterium tuberculosis that do not code for known drug-resistance mechanisms. J Infect Dis. 2010, 201:881-8. PMID: 20136412 |
| Blakemore R, Story E, Helb D, Kop J, Banada P, Owens MR, Chakravorty S, Jones M, Alland D . Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol . 2010 48 :2495-501. PMID: 20504986. |
| Wang F, Jain P, Gulten G, Liu Z, Feng Y, Ganesula K, Motiwala AS, Ioerger TR, Alland D , Vilchèze C, Jacobs WR Jr, Sacchettini JC. Mycobacterium tuberculosis Dihydrofolate reductase is not a target relevant to the anti-tubercular activity of isoniazid. Antimicrob agents chemother. 2010 Jun 21. [Epub ahead of print] PMID: 20566771. |
Areas of Interest
Current Research
Rapid diagnostics for biodefense
The advent of bioterrorism has placed a new emphasis on the need for rapid diagnostic assays that are sufficiently simple and robust that they can be performed in a doctor's office, clinic or local hospital. Blood cultures are one of the most common methods for detecting infections in patients with fever. A rapid "molecular" version of a blood culture would fulfill many of the diagnostic needs in health care settings for biodefense. The Alland laboratory has been working to develop a "molecular blood culture" that will make it possible to identify all common medical pathogens from blood samples in under an hour, without the need for conventional culture methods.